Keyphrases
Pharmacokinetics
100%
Insulin-like Growth factor-1
100%
Enhancing Antibody
100%
Tissue Distribution
100%
125I
16%
Radioactivity
13%
Trichloroacetic Acid
11%
Immunoglobulin
11%
Non-immune
8%
Skeletal muscle
5%
Liver
5%
Kidney
5%
Binding Capacity
5%
Plasma Pool
5%
Decay Curves
5%
Treatment Group
2%
Size Exclusion Chromatography
2%
Bioavailable
2%
Molecular Mass
2%
Treatment Strategy
2%
Polyclonal Antibody
2%
Jugular Vein
2%
Pharmacokinetic Parameters
2%
Antiserum
2%
I to
2%
Two-phase Model
2%
Clearance Rate
2%
Plasma Clearance
2%
Low Affinity
2%
Non-self
2%
IGF-1 Treatment
2%
Insulin-like Growth Factor Binding Protein (IGFBP)
2%
Antigenic Site
2%
Plasma Tissue
2%
Total Clearance
2%
Clearance Distribution
2%
Growth-promoting Activity
2%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Tissue Distribution
100%
Pharmacokinetics
100%
Immunology
100%
Iodine-125
37%
Blood Plasma
25%
Immunity
18%
Skeletal Muscle
12%
Antiserum
6%
Size Exclusion Chromatography
6%
Clearance
6%
Molecular Weight
6%
Immunoglobulin Antibody
6%
Plasma Clearance
6%
Dwarf Rat
6%
Polyclonal Antibody
6%
Jugular Vein
6%
Neuroscience
Intravenous Immunoglobulin
100%
Pharmacokinetics
100%
Iodine-125
37%
Blood Plasma
31%
Skeletal Muscle
12%
In Vivo
6%
Immunoglobulin Antibody
6%
Polyclonal Antibody
6%
Antiserum
6%
Gel Permeation Chromatography
6%